Dinetic AG is a biotech company founded in 2021, dedicated to research, development, innovation and production of premium health support products to improve the standard of living.

Our Mission

At Dinetic AG, we are devoted to providing our customers with cutting-edge phytochemical solutions. Our mission is to deliver safe and certified plant-based compounds with proven health benefits. We aim to establish ourselves as pioneering research specialists in this developing field.

Our innovative business model, proprietary processes, and cutting-edge technologies define who we are. By fostering strong collaborations with established partners and institutions, we adapt to the dynamic needs of a growing industry.

Dinetic AG is committed to driving positive, lasting contributions for customers, partners, and communities. Our mission is to create persistent benifical change. 

Corporate Vision

At Dinetic AG, our vision is to revolutionize well-being by harnessing the synergistic potential of diverse phytomolecules derived from safe, natural plant sources. Through an evidence-based approach, we are dedicated to creating innovative, high-quality, and sustainable formulations that enhance health and quality of life. As part of our research plan, we are exploring various health areas where our findings can be applied. We strive to expand access to natural, scientifically-supported solutions, empowering individuals to achieve their best selves.

01
100% delivery reliability thanks to our own supply chain throughout the entire value chain
02
Own bioactive profiling method developed for all plants
03
Scalability of the application areas of transdermal application is enormous

Our USP's

04
Experienced team with an agile organizational form around market requirements
05
Well connected to various biotech companies, universities, research institutes
06
Introduce focus on own quality standard with bioactive profiling protocol

Our Milestones

2020
  • Desk Research, Potential evaluation
  • Planning and concept development, Market research
  • Team creation
2021
  • Business foundation
  • Start of Research
  • Start with plant analysis
  • Start of production
2022
  • Research start with INRAE (National Institute of Agronomy Research)
  • Extraction method (development (Bioprofiling), documentation, preparation for patent)
  • Fractionation (plant analyzed and fractionated)
  • Sales start seedlings
2023
  • Test our fractions and our enhancers against different diseases with the ex vivo, in vitro, in vivo model.
  • Application for the patents for our bioprofiling
  • End product development/production (product development through our own research experience)
2024
  • Breeding of own plant genetics for optimal yield of the molecules
  • Market release of transdermal application
2025
  • Set standards in the market (Through many representative customers)



Our Partners

We use Cookies to measure the performance of our website. Do you want to accept these?